Henan Lingrui Pharmaceutical Co., Ltd.

SHSE:600285 주식 보고서

시가총액: CN¥14.5b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Henan Lingrui Pharmaceutical 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Wei Xiong

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권0.6%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

May 07
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

May 02
Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Mar 04
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Feb 29
Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

CEO

Wei Xiong (38 yo)

no data

테뉴어

CN¥1,772,800

보상

Mr. Wei Xiong serves as General Manager and Director at Henan Lingrui Pharmaceutical Co. Ltd. and served as its Chairman and Managing Director.